Rankings
▼
Calendar
INSM Q1 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$53M
+32.1% YoY
Gross Profit
$41M
77.0% margin
Operating Income
-$90M
-169.2% margin
Net Income
-$95M
-178.2% margin
EPS (Diluted)
$-0.80
QoQ Revenue Growth
-5.4%
Cash Flow
Operating Cash Flow
-$105M
Free Cash Flow
-$107M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$1.0B
Stockholders' Equity
$120M
Cash & Equivalents
$516M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$53M
$40M
+32.1%
Gross Profit
$41M
$30M
+34.7%
Operating Income
-$90M
-$84M
-7.2%
Net Income
-$95M
-$92M
-3.3%
Geographic Segments
JAPAN
$11M
75%
UNITED STATES
$4M
25%
← FY 2022
All Quarters
Q2 2022 →